ABSTRACT: This study was conducted to examine whether Cu could exert its growth-promoting effect when injected, rather than being fed, and thus bypass the gastrointestinal tract. In two 18-d experiments, pigs were injected every 2 d with a Cu histidinate or histidine solution. Amounts of Cu injected were calculated t o simulate varying absorption rates in pigs fed 250 ppm of dietary Cu. In Exp. 1, 44 pigs were randomly assigned to four groups of 11 pigs each. Pigs were injected with four levels of Cu histidinate (0, 5, 10, and 15% estimated apparent absorption coefficients based on calculated feed intake). Average daily gain responded quadratically ( P < .05) to levels of Cu histidinate; maximum growth was seen in the 5% group. At d 6, serum mitogenic activity also exhibited a similar quadratic response ( P < .05). In Exp. 2, estimated Cu absorptions of 0, 2, 4, 6, and 8% were tested. Forty-five pigs were randomly assigned to five groups of nine pigs each and injected as in Exp. 1. Both ADG and serum mitogenic activity displayed a quadratic response ( P < .05); the maximum response was seen in the 4% group. Liver Cu content, superoxide dismutase activity, and serum Cu concentrations were linearly increased ( P < .05) with increasing dosage of Cu in both Exp. 1 and 2. Also, brain Cu content linearly increased ( P < .05) with increasing dosage of Cu in Exp. 1 and 2. Pituitary growth hormone mRNA concentrations in Exp. 2 were not significantly influenced by treatments. This study shows that Cu may stimulate growth when injected intravenously, thus bypassing the gastrointestinal tract. Therefore, a mode of action that does not involve antimicrobial activity should be considered.
Introduction
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5Animal Nutr. Dept., Agricultural Univ. Wageningen, Haagsteeg J. h i m . Sci. 1994 Sci. . 72:2395 Sci. -2403 Cu has been observed (Bowland et al., 1961; Cromwell et al., 1989) , which suggests the possibility of a systemic action for Cu. Yen and Nienaber ( 1993) said that mechanisms other than reduced oxidative demand by portal vein-drained organs may be responsible for the growth-stimulating effect of high dietary Cu. However, direct evidence supporting a systemic growth-promoting action of copper is lacking. One way to test the systemic action of copper is to inject copper directly into blood circulation and thus bypass the gastrointestinal tract. Gipp et al. (1973) first attempted t o inject Cu in pigs. They used subcutaneous injections of cupric glycinate, but pigs developed severe abscesses at the sites of injection, and the injections had to be discontinued. The toxicity of subcutaneously injected Cu has also been shown in sheep and cattle and is unlikely to be avoided by using other forms of Cu (Allen and Mallinson, 1984) . In a pilot experiment, daily intravenous injections of a Cu histidinate solution given to weanling pigs were found to produce no obvious abnormalities around sites of injection, and injected pigs performed well. Therefore, it seems that an intravenous injection of Cu histidinate was a safe way to deliver Cu into pigs. The objective of this study was to examine the effect of intravenously injected Cu on growth, tissue Cu deposition, hepatic superoxide dismutase activity, serum mitogenic activity, and growth hormone gene expression.
Materials and Methods
Copper Complexes and Injection Dosage. The free cupric ion (Cu2+) has a high affinity for biomolecules and thus is highly toxic (Jameson, 1987) ; therefore, a Cu complex, Cu histidinate, was used in our injection experiments. The Cu histidinate complex, prepared by mixing CuC12 with a L-histidine solution (Barnea et al., 1990) , was used because this complex normally functions as a transport form of Cu in the blood (Harris, 1991) . This complex is believed to have a relatively high uptake rate into the brain and several other tissues (Barnea et al., 1990) .
The assumption was made that the amount of Cu injected should be close to the normal amount of Cu absorbed when pigs are fed high-Cu diets. Because growth stimulation is usually greatest for pigs fed diets containing 250 ppm of Cu, the injected dosage of Cu was estimated based on this dietary level of Cu, using the following equation:
, where Cu AD = Cu apparent digestibility or absorption coefficient, ADFI = average daily feed intake, 250 = Cu normally supplemented in a high-Cu diet, and TI = injection interval of every other day (= 2).
The following regression formula, generated using data from a previous feed intake experiment (Ogunbameru et al., 19921 , was used to estimate feed intake for individual pigs according to their body weights:
Feed intake (kg/d) = -.725 + .233 x BW.73 (kg).
Apparent absorption coefficients of Cu in weanling pigs were reported to range from 5 t o 20% (Roof and Mahan, 1982) . Therefore, several levels of estimated apparent Cu absorption were tested as treatments.
Animals and Treatments. All pigs used in this study
were Yorkshire-Duroc crossbred weanling pigs. They were individually housed in environmentally controlled rooms equipped with cages (.61 m x .91 m ) with plastic-coated, woven wire flooring. Temperature was maintained at recommended levels (Hinkle et al., 1978) and rooms were designed to provide 13.5 air changes per hour. After weaning, pigs were given an adjustment period of 6 d before the start of the experiment. During the adjustment and experimental periods, all pigs had ad libitum access to a fortified, corn-soybean meal diet containing 20% CP and 18 ppm of Cu (Table 1) .
In Exp. 1, 44 pigs (barrow, average BW, 6.6 kg) were randomly assigned to four treatments from outcome groups based on weight. Littermates were Feed intake was determined every 6 d, and blood samples were taken from the anterior vena cava on the same day before injections. Plasma samples were collected using vacuum tubes coated with sodium heparin (Becton DicksonNacutainer systems, Rutheford, N J ) and were immediately used for hemoglobin assay. Serum samples were stored a t -80°C for later analyses. After 18 d, all pigs were killed by electrocution and exsanguination. Brain, liver, thyroid, and pituitary glands were collected. Brain and liver were immediately frozen at -20°C for later mineral analysis. Pituitary glands were frozen in liquid nitrogen and kept at -80°C. A portion of the longissimus muscle was also collected and weighed. The muscle sample was separated from the distal part of the shoulder to the proximal part of the innominate bone.
In Exp. 2, based on the findings of Exp. 1, estimated apparent absorption coefficients of 0, 2, 4, 6, and 8% were used to determine the most effective injection dosage of Cu. Forty-five crossbred pigs (barrows, average BW, 7.1 kg) were randomly assigned into five groups of nine pigs each. Experimental procedures were similar to those used in Exp. 1, except kidney and thyroid samples were not collected, and the entire longissimus muscle was taken.
Serum Mitogenic Activily. Serum mitogenic activity was measured by a procedure developed in our laboratory and described by Zhou et al. (1994a,b) . Mitogenic activity was expressed as difference in absorbance values (OD540nm-OD690nm), which is a measurement of cell number.
Pituitary Growth Hormone mRNA. The isolation of total RNA from whole pituitary glands, the preparation of the specific probe for the porcine growth hormone gene, the hybridization of the membranes with the probe, and the scanning of the authoradiogram were described by Zhou et al. (199413) .
Other Analyses. Liver samples were prepared and assayed for superoxide dismutase activity (Prohaska, 1983) . Plasma hemoglobin concentration was measured by the cyanmethemoglobin method using a Sigma kit (Sigma Chemical, St. Louis, MO). Serum samples were diluted with distilled water and the Cu concentration was measured with an atomic absorption spectrophotometer (Model 5100, Perkin Elmer, Nonvalk, CT). Whole organs were homogenized with a blender. Samples of the homogenates were wetdigested with nitric acid and perchloric acid (AOAC, 1990) . Mineral (Cu, Zn, and Fe) concentrations were measured by flame atomic absorption spectrophotometry. Certified mineral reference solutions (Fisher Scientific, Fair Lawn, N J ) were used as standards.
Dry matter contents of tissue homogenates were also determined (AOAC, 1990). Tissue mineral concentrations were expressed on a dry matter basis.
Duta Analysis. Data were analyzed using the GLM procedures of SAS (1988). Individual pig was the experimental unit. The model initially included treatment, room, replicate, and replicate within room. The effect of different levels of Cu was tested by orthogonal polynomial contrasts. Orthogonal polynomial contrasts were calculated according to Cady and Fuller (1968) .
Results
Plasma Hemoglobin and Serum Copper Concentrations. In Exp. 1, hemoglobin concentration was generally reduced as the level of injected Cu increased, but the linear effect was only significant ( P < .05) at d 12 ( Table 2) . A decrease in the hemoglobin concentration suggested a mild Cu toxicity in the high dose groups. The concentration of hemoglobin was not significantly influenced by Cu injection in Exp. 2 (Table 3) . In both Exp. 1 and 2, serum Cu concentration was generally increased (linear, P < .05) as the Cu injection level increased; the magnitude of the increase was greatest for the highest injection group.
Growth Performance. In Exp. 1, ADG quadratically ( P c .05) responded to increasing levels of Cu histidinate; maximal growth was seen in the 5% group during the 18-d experiment ( Table 4 ) . Increasing injection level of Cu decreased ( P < .05) ADFI linearly during the last 6-d period. Numerically, the effect of Cu on ADFI was quadratic in other periods and overall; the highest ADFI was seen in the 5% group. Similarly, injected Cu tended to have a quadratic effect ( P < . l o ) on cumulative gain per feed ( GF), with the highest GF in the 5% group. In Exp. 2, the 18-d ADG displayed a quadratic trend ( P < .05) with the maximum response in the 4% injection group (Table 5 ). The quadratic trend was present numerically in all periods but was only significant ( P < .05) during d 13 to 18. Injection of Cu linearly increased ( P < .05) ADFI during d 13 to 18, but ADFI generally followed ADG trends, displaying a quadratic response to Cu dosage. During d 7 to 12, d 13 to 18, and overall, GF was improved linearly ( P < .05) by Cu injection.
Organ Weight. In both Exp. 1 and 2, Cu injection had no significant effect on the absolute or relative weight of brain, liver, or thyroid, which indicates that relative growth of these organs was normal. In Exp. 1, overall means ( k SE) were 390.2 k 10.1 g and 32.8 k .4 g k g BW for liver, 51.2 f 1.2 g and 4.4 f .15 g k g BW for brain, and 8.7 k .2 g and 74.0 k 1.5 mgkg BW for thyroid, respectively, for absolute and relative weights. In Exp. 2, overall means were 430.0 k 12.8 g and 33.5 f .65 g k g BW for liver and 48.3 k .7 g and 3.8 k .1 g/kg BW for brain, respectively, for absolute and relative weights. In Exp. 1, increasing levels of injected Cu linearly increased ( P < .05) the relative weight of the longissimus muscle (Table 6) . Numerically, Cu-injected groups in Exp. 2 also had heavier muscles ( Table 7 ) . This suggests that Cu injection stimulates the growth of longissimus muscle more than that of the whole body. In Exp. 1, relative kidney weight was also linearly increased ( P < . 0 5 ) by Cu injection.
Tissue Mineral Contents. In Exp. 1 and 2, the Cu concentration in the liver increased linearly ( P < . 0 5 ) as the Cu injection dosage increased, with a 40-fold increase for liver at the highest Cu injection level in Exp. 1 (Tables 8 and 9 ). Liver Zn concentration was linearly increased ( P < .05) by increasing levels of Cu injection in both Exp. 1 and 2. In Exp. 1, Fe concentration of the liver was elevated by 55% in the 15% group, which resulted in a quadratic effect of Cu dosage ( P < .05). No significant effect of Cu on hepatic Fe concentration was observed in Exp. 2.
Brain Cu concentration increased linearly ( P < .05) in both Exp. 1 and 2 (Tables 8 and 9 ). Zinc concentration in the brain was not affected by treatments. In Exp. 1, a small linear decrease ( P < T'reatments 0, 5, and 10% represent 11 pigs, and treatment 15% represents 10 pigs.
bLinear effect ( P < .05). CQuadratic effect ( P < .05). dQuadratic effect ( P < .lo). aEach mean represents nine pigs.
bLinear effect ( P < .05).
CQuadratic effect ( P < .05).
increase in activity is rather small compared with the dramatic rise in liver Cu deposition.
Growth Regulatory System. In Exp. 1, the 5% Cu injection group had the highest level (quadratic effect, P < .05) of serum mitogenic activity at d 6 and 12 of the 18-d study ( Figure 2a ) compared with the other groups. In Exp. 2, serum mitogenic activity was generally increased by all Cu-injected groups, with a quadratic effect ( P < .05) at d 12 and 18 (Figure 2b ). At d 6, serum mitogenic activity was linearly increased by the 2, 4, and 8% group but not by the 6% group, which resulted in a quadratic effect ( P < .05). This corresponds well to the slow growth rate of this group during d 1 to 6 ( Table 5 ) . The GH oligonucleotide probe was hybridized with a major band of 1 kb and three minor bands of higher molecular weight (Figure 3 ) . Because the molecular weight of the major band corresponds well with the predicted size of mature porcine GH mRNA (Vize and Wells, 1988> , only the major band was quantified. In Exp. 1 and 2, GH mRNA levels were increased slightly in response to increasing levels of injected Cu ( Figure  4) ; however, the treatment effect was not significant.
Discussion
Systemic Growth-Promoting Action of Copper. Our experiments provide direct evidence that parenterally administrated Cu is able to promote growth in weanling pigs. There are two possible ways that the intravenously injected Cu could affect growth. ,First, it is possible that injected Cu may be released into the gastrointestinal tract through the bile and act enterically. Excretion of small amounts of injected Cu into the bile of pigs has been reported (Skalicky et al., 1985) . However, the amounts of Cu injected in our study were so small (10 to 20 mg/d) that even if a significant portion of it is released into the gastrointestinal tract, it would not greatly increase the Cu aTreatments 0, 5, and 10% represent 11 pigs, and treatment 15% represents 10 pigs. bA portion of the longissimus muscle.
CLinear response ( P < .05). concentration of the intestinal contents. Furthermore, the Cu excreted from the bile is in bound forms (Mason, 19791 , which is predicted to lower its putative antimicrobial activity (Trevors and Cotter, 1990) . Therefore, significant enteric action is unlikely. Thus, the second possibility, that Cu acts systemically, is most likely. It is important to point out, however, that systemic growth-promoting actions of Cu shown in both experiments would not rule out a possible enteric growth-promoting action of Cu in pigs fed Cu.
One interesting observation is that Cu stimulated the growth of longissimus muscle more than that of the whole body. Myres and Bowland (1973) also observed larger loin cross-sections of pigs fed with high-Cu diets than of those receiving no supplemental Cu. The impact of Cu on muscle growth should be examined further.
Copper MetaboZism. Pigs injected with Cu showed a quadratic growth response similar to that obtained when pigs were fed Cu (Wilson et al., 1979; Cromwell (Cromwell et al., 1989; Kornegay et al., 1989) . This suggests that injection of pigs with the growthstimulating level of Cu (2, 4 or 5% Cu estimated absorption) results in a liver Cu content similar t o that achieved by feeding 200 ppm of Cu. Therefore, the dosage of Cu used may closely mimic Cu feeding. Liver superoxide dismutase activity was found to be increased by Cu injection. Superoxide dismutase is a cuproenzyme functioning as a free radical scavenger (Prohaska, 1991) . Our results show that injected Cu is not only able to be deposited in the brain and liver, but also is incorporated into cuproenzymes. 
I
The Role of the Growth Regulatory System in Copper-Stimulated Growth. Injected Cu stimulated serum mitogenic activity. An increased serum mitogenic activity was also observed in pigs fed high-Cu diets (Zhou et al., 199413) promoting serum mitogenic activity is unclear. Our results concerning the pituitary GH gene expression are not conclusive. Additional quantitative methods may be necessary in the future to characterize the interactions between Cu and growth hormone gene expression. The impact of high dietary or injected Cu on the growth regulatory system has not been well studied. However, it is known that intravenously injected Cu stimulates the secretion of several neuropeptides in the hypothalamus (Tsou et al., 1977; Barnea and Cho, 1987) . Copper was also found to stimulate GH secretion from bovine pituitary explants in vitro (LaBella, 1973) . Copper is involved in the post-translational modification of regulatory peptides (Eipper and Mains, 1988) and has been found to be a component of the growth factor Iamin (Parkart, 1987) . Therefore, it is possible for Cu to influence the growth regulatory system in many ways. By examining the mechanism for the induction of Cu-stimulated serum mitogens, it will be possible to locate specific interactions between Cu and the growth regulatory system, which may eventually lead to the elucidation of the mode of action of Cu.
Implications
Copper has been used as a growth promoter for many years. The mode of action of copper is still not clear. Results from these experiments suggest that copper can act systemically to promote growth. Therefore, future development of copper as a growth promoter should concentrate on improving the efficiency of delivering copper into the circulation, rather than improving antimicrobial activity. 
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